28th March 2004
Your doctor is nuts to put you on both , it is even stated in the tricor side effects that is not worth the risk . Below are direct quotes from the tricor literature .
HMG-CoA reductase inhibitors: Rhabdomyolysis has occurred when lovastatin was administered in combined therapy with gemfibrozil, a compound of the fibrate class related to fenofibrate. In most patients who have had an unsatisfactory lipid response to either drug alone, any possible benefit of combined therapy with an HMG-CoA reductase inhibitor and TRICOR is not outweighed by the risks of severe myopathy, rhabdomyolysis, and acute renal failure. There is no assurance that periodic monitoring of creatine kinase will prevent the occurrence of severe myopathy and kidney damage.
HMG-CoA reductase inhibitors: Rhabdomyolysis has occurred when lovastatin was administered in combined therapy with gemfibrozil, a compound of the fibrate class related to fenofibrate. In most patients who have had an unsatisfactory lipid response to either drug alone, any possible benefit of combined therapy with an HMG-CoA reductase inhibitor and TRICOR is not outweighed by the risks of severe myopathy, rhabdomyolysis, and acute renal failure. There is no assurance that periodic monitoring of creatine kinase will prevent the occurrence of severe myopathy and kidney damage.